Hello guest, Register  |  Sign In
Virologica Sinica, 31 (1) : 81-84, 2016
Letter
Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia
1. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), The Children’s Hospital at Westmead, and the Discipline of Paediatrics and Child Health, Sydney Medical School, The University of Sydney, Sydney, NSW 2145, Australia
2. University of Technology Sydney, School of Medical and Molecular Biosciences, Broadway, Sydney, NSW 2007, Australia
3. School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia
4. Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Biological Sciences and Sydney Medical School, The University of Sydney, NSW 2145, Australia
5. WHO Collaborating Centre for Mass Gatherings and High Consequence/High Visibility Events, Flinders University, Adelaide,SA 5001, Australia
 Correspondence: Gouri.Banik@uts.edu.au
(4322.04KB)  
Abstract
To date, Middle East respiratory syndrome coronavirus (MERS-CoV) has affected over 1600 individuals in 26 countries across the globe, claiming 40% lives and thus poses a great public health challenge to the Middle East and elsewhere. Risk factors for mortality and severity among MERS patients are poorly understood. To address this, the author analysed a large dataset from Saudi Arabian Ministry of Health (MOH) in order to explore key risk factors for mortality and severity, and found that people with certain co-morbid conditions (diabetes, hypertension, renal disease, malignancy, miscellaneous conditions) were at particularly higher risk of dying or suffering severe outcome of MERS-CoV.
Key Words:
Received: 11 Nov 2015  Accepted: 12 Jan 2016  Published online: 25 Jan 2016
Home |  Resources |  About Us |  Support |  Contact Us |  Privacy |  Powered by CanSpeed | 
Copyright © 2015 Virologica Sinica. All rights reserved